Analytics in Action News

Mayo Clinic Platform Strikes Partnership to Analyze Medical Device Use

Mayo Clinic Platform is partnering with Becton, Dickinson and Company to perform post-market surveillance on the company’s products in an effort to fuel innovation and gain insights into patient experience.

Various medical and AI tools drawn on a light blue background

Source: Getty Images

By Shania Kennedy

- Mayo Clinic Platform, Mayo Clinic’s portfolio of digital healthcare initiatives, has partnered with medical technology company Becton, Dickinson and Company (BD) to utilize de-identified patient data to perform detailed post-market analysis on BD’s medical device offerings, with the goal of fueling healthcare innovation and forecasting unmet patient needs.

The partnership will utilize Mayo Clinic Platform_Discover, one of the platform’s de-identified patient datasets, for analysis. The dataset is comprised of structured and unstructured data from 10 million patients across clinical specialties, including 1.2 billion lab test results, 3 million echocardiograms, and more than 640 million clinical notes. The dataset also contains information related to diagnoses, pathology and radiology reports, and medications.

Mayo Clinic Platform_Discover is designed to give artificial intelligence (AI) developers access to large amounts of healthcare data to help them build algorithms. Data is continuously refreshed and added as patients travel across the care continuum to make the dataset more robust over time. All data is de-identified, and the platform uses a multi-layer, re-identification defense strategy to protect patient privacy.